Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Samuel Isaly, Orbimed Advisors Disclose Position in Post-IPO Relypsa

Sam Isaly’s Orbimed Advisors disclosed its position in Relypsa Inc (NASDAQ:RLYP), a company that recently conducted its IPO. Orbimed reported holding around 3.2 million of Series B-1 Preferred Stock, and some 3.7 million of Series C-2 Preferred Stock. At the same time, Orbimed holds warrants to purchase stock, equal to over 1.7 million shares of Series C-1 Preferred Stock.

Relypsa

Disclosure: none

Recommended Reading:

Cliff Asness, AQR Capital Like Exxon Too, Also Bullish on Chevron

Jeff Smith, Starboard Trim Stake in Emulex

Pentwater Capital Management Adds Stewart Enterprises to Equity Portfolio

Loading...